Scientists design non-hallucinogenic psychedelic treatments potentially accelerating research on mental health benefits

Researchers identified 5-hydroxytryptamine 2A (5-HT2A) receptor (5-HT2AR) signaling pathways associated with psychedelic potential.

Research identifies key stressors impacting midwives’ wellbeing

Research into stress among midwives has identified the most effective actions individual midwives and healthcare trusts can make to enhance wellbeing and reduce negative outcomes,

December 19, 2024

Experts identify key strategies to combat tooth decay in young children

Researchers at The University of Manchester have identified several ways for health leaders to tackle the problem of tooth decay in children in England.

November 25, 2024

ASCO preview: a promising solid tumor CAR-T, an AI patient navigator, and improving palliative care

Thousands of cancer researchers and clinicians are flocking to Chicago for the American Society of Clinical Oncology annual meeting that starts Friday. The ASCO meeting

May 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.